Horizons in Cancer Research presents original research results on the leading edge of cancer. Topics discussed include paclitaxel in chemotherapy and neurotoxicity; the role of prostate-specific antigen (PSA) in pathological angiogenesis and prostate tumour growth; second primary cancer in children and adults; CD133 as a cancer stem cell marker; psychosocial oncology; brain metastases and target therapy for DSB repair deficient tumours; and management of recurrent cervical carcinoma.
Preface; Paclitaxel:: Chemotherapy & Neurotoxicity-The Two Sides of the Coin; Role of Prostate-Specific Antigen (PSA) in Pathological Angiogenesis & Prostate Tumor Growth; Proteomics in the Discovery of Biomarkers of Chemoresistance:: The Current Status of Paclitaxel Resistance in Human Epithelial Ovarian Cancer; Macromolecules as Paclitaxel Carriers:: From Chemical Considerations to Clinical Applications; Paclitaxel Crystals:: Molecular Interactions, Nucleation & Growth, & Possible Implications on Cell Studies; Second Primary Cancer in Children & Adults:: A Comparison; Critical Evaluation of the Use of CD133 as a Cancer Stem Cell Marker in Solid Tumors; Psychosocial Oncology; Brain Metastases:: Symptoms, Diagnosis & Treatment; Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer.
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.